Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells von Simbulan-Rosenthal, Cynthia M, Haribabu, Yogameenakshi, Vakili, Sahar, Kuo, Li-Wei, Clark, Havens, Dougherty, Ryan, Alobaidi, Ryyan, Carney, Bonnie, Sykora, Peter, Rosenthal, Dean S

Volltext

CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma von Simbulan-Rosenthal, Cynthia M, Islam, Nusrat, Haribabu, Yogameenakshi, Alobaidi, Ryyan, Shalamzari, Azadeh, Graham, Garrett, Kuo, Li-Wei, Sykora, Peter, Rosenthal, Dean S

Volltext

Abstract 6142: Inhibition of both MAPK and AKT pathways overcomes resistance of NRAS-mutant melanoma stem cells to apoptosis von Alobaidi, Ryyan, Islam, Nusrat, Zhang, Yanjun R., Shamo, Mathew M., Allsup, Samuel, Simbulan-Rosenthal, Cynthia M., Rosenthal, Dean S.

Volltext

Abstract 348: Efficacy of triple combination treatment with trametinib, mebendazole and CD133 RNA aptamer in recalcitrant NRAS-mutant melanoma cells von Haribabu, Yoga, Chien, Raymond, Alobaidi, Ryyan, Kuo, Li-Wei, Islam, Nusrat, Simbulan-Rosenthal, Cynthia M., Rosenthal, Dean S.

Volltext

Chemotherapy‐mediated pain and peripheral neuropathy: impact of oxidative stress and inflammation von El‐Fawal, Hassan A.N, Rembisz, Robert, Alobaidi, Ryyan, Mousa, Shaker A

Volltext